Geron Corporation

$1.27
(as of Apr 17, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Geron Corporation

Stock Price
$1.27
Ticker Symbol
GERN
Exchange
NASDAQ

Industry Information for Geron Corporation

Sector
Healthcare
Industry
Biotechnology

Company Description for Geron Corporation

Website
https://www.geron.com
Country
USA
Full Time Employees
229

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Fundamentals for Geron Corporation

Market Capitalization
$808,879,552
EBITDA
$-173,186,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-0.27
Earnings per Share Estimate Next Year
Profit Margin
-226.74%
Shares Outstanding
636,913,024
Percent Owned by Insiders
0.09%
Percent Owned by Institutions
83.38%
52-Week High
52-Week Low

Technical Indicators for Geron Corporation

50-Day Moving Average
200-Day Moving Average
RSI
34.43
ATR
0.13

Analyst Ratings for Geron Corporation

Strong Buy
5
Buy
4
Hold
0
Sell
0
Strong Sell
0

News About Geron Corporation

Apr 18, 2025, 4:30 PM EST
FOSTER CITY, Calif., April 18, 2025--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 1,551,000 shares of its common stock, consisting of stock options to purchase an aggregate of 1,034,000 shares of common stock and restricted stock units ("RSUs") representing an aggregate of 517,000 shares of common stock, to twelve newly hired employees as an inducement material to their acceptance of employment with the Company. See more.
Apr 18, 2025, 1:00 PM EST
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN) of a class action securities lawsuit. See more.
Apr 18, 2025, 11:45 AM EST
We recently published a list of the 11 Most Promising Penny Stocks According to Analysts. See more.
Apr 18, 2025, 11:30 AM EST
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- See more.